1. An R0-resectable, Genetically Engineered Mouse Model of Pancreatic Cancer Mimics the Response to Neoadjuvant Chemotherapy in Human PDAC. (2021) Authors: Mota Reyes, C.; Mundt, B.; Brooks, J.; Konukiewitz, B.; Muckenhuber, A.; Teller, S.; Weichert, W.; Friess, H.; Florian, K.; Ceyhan, G.O.; Demir, I.E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. (29th September 2016) Authors: Dieter, S. M.; Heining, C.; Agaimy, A.; Huebschmann, D.; Bonekamp, D.; Hutter, B.; Ehrenberg, K. R.; Fröhlich, M.; Schlesner, M.; Scholl, C.; Schlemmer, H.-P.; Wolf, S.; Mavratzas, A.; Jung, C. S.; Gröschel, S.; von Kalle, C.; Eils, R.; Brors, B.; Penzel, R.; Kriegsmann, M. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0578: New technologies for genomic tumour profiling. (April 2016) Authors: Weichert, W. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PH-0719: 18F-FDG-PET/CT parameters as predictors of survival and response to nCRT in esophageal cancer. (November 2020) Authors: Marr, L.; Pyka, T.; Peeken, J.C.; Haller, B.; Jesinghaus, M.; Weichert, W.; Weber, W.; Combs, S.E.; Münch, S. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Issue 4 (March 2015) Authors: Tinhofer, I.; Jöhrens, K.; Keilholz, U.; Kaufmann, A.; Lehmann, A.; Weichert, W.; Stenzinger, A.; Stromberger, C.; Klinghammer, K.; Becker, E.-T.; Dommerich, S.; Stölzel, K.; Hofmann, V.M.; Hildebrandt, B.; Moser, L.; Ervens, J.; Böttcher, A.; Albers, A.; Stabenow, R.; Reinecke, A. Journal: European journal of cancer Issue: Volume 51:Issue 4(2015:Mar.) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.). (January 2017) Authors: von Laffert, M.; Schirmacher, P.; Warth, A.; Weichert, W.; Büttner, R.; Huber, R.M.; Wolf, J.; Griesinger, F.; Dietel, M.; Grohé, Ch. Journal: Lung cancer Issue: Volume 103(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Histopathological Characterization of Ovarian Neoplasms in BLMM3/M3 Mice. (January 2020) Authors: Ballke, S.; Burger, S.; Noske, A.; Yen, H.; Rad, R.; Weichert, W.; Steiger, K. Journal: Journal of comparative pathology Issue: Volume 174(2020) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dog Cancer Panel: Targeted Massive Parallel Sequencing Detects Somatic and Germline Mutations. (January 2020) Authors: Steiger, K.; Aupperle-Lellbach, H.; Gruber-Beckmann, B.; Reiser, M.; Wirges, N.; Weichert, W.; Pfarr, N. Journal: Journal of comparative pathology Issue: Volume 174(2020) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. (April 2016) Authors: Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A.L.; Abdollahi, A.; Debus, J. Journal: European journal of cancer Issue: Volume 57(2016) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EP-1410: Comparison of neoadjuvant chemoradiation with carboplatin/paclitaxel or CDDP/5-FU for esophageal SCC. (April 2018) Authors: Münch, S.; Pigorsch, S.; Feith, M.; Slotta-Huspenina, J.; Weichert, W.; Friess, H.; Combs, S.; Habermehl, D. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗